With the rise in resistance to antibiotics such as methicillin, there is a need for new drugs. The invention provides small molecules that inhibit cellular drug targets such as UPPS and FPPS by interacting with binding pockets, thereby preventing enzyme function. Compounds described herein are also active against Staphylococcus aureus (MIC90 ~0.25 µg/mL), can potently synergize with methicillin (fractional inhibitory concentration index = 0.25), and are protective in a mouse infection model. The invention therefore provides numerous compounds for anti-bacterial treatments and for restoring sensitivity to drugs such as methicillin, using combination therapies.
HEINICKE J.; BOEHLE I.; TZSCHACH A., J. ORGANOMET. CHEM., 317,(1986) N 1, 11-21
作者:HEINICKE J.、 BOEHLE I.、 TZSCHACH A.
DOI:——
日期:——
1,3-carbanionische umlagerungen: Reaktionen von phosphorsäure-o-haloarylestern mit metallen zu arylphosphonsäurederivaten
作者:J. Heinicke、I. Böhle、A. Tzschach
DOI:10.1016/s0022-328x(00)99340-9
日期:1986.12
o-Bromoaryl esters of phosphoricacid react with magnesium to give arene phosphonic acidderivatives via intermediate Grignard compounds. Similar metallation rearrangement processes may be achieved in the case of o-chloroaryl esters if sodium is applied as metal. 2,4-Dibromoaryl esters are attacked by magnesium regiospecifically in o-position.